Montreal, October 6th, 2015. – CQDM and AiF Projekt GmbH, the project management agency of BMWi, the German Ministry for Economic Affairs and Energy, are very pleased to announce the launch of a new international funding initiative entitled the Canada/Germany joint program, within CQDM’s Canada/Europe joint funding initiative. This collaboration agreement aims at funding collaborative research between the two countries. The main goal of the Canada/Germany joint program is to strengthen research in Canada and Germany by aligning scientific resources and expertise. This gives the opportunity to R&D projects jointly conducted by Canadian and German private and public research entities to develop new expertise and to expand into new markets.
Each project will benefit from a funding between $500k and $1M over a two or three year period. The contribution by Germany, intended to the German research entities involved in the project, will be provided by the Central Innovation Program for SMEs (ZIM Cooperation projects) and is technology open. Funds provided by Canada, for the Canadian research organizations collaborating on the project, will come from CQDM and is aimed at creating value for the life sciences and biopharmaceutical industry.
To see the call for proposals and to know more about the Program’s requirements, we invite you to visit our website at: https://cqdm.org/en/programs-and-competitions/canada-germany-program.php
Applicants will have until January 15th, 2016 to apply. German researchers are invited to submit their letters in intent with AiF Projekt GmbH and Canadian researchers with CQDM.
Interested applicants will have the opportunity to hear about the Program and also meet with partners at the Germany-Canada Networking Breakfast organized by BIO-M and BIOTECanada at BioEurope Munich on November 3, 2015, at 8:00 a.m. (CET). The Networking Breakfast will take place in the Exhibition Hall – BioM (booth #74) of the International Congress Center, Messe Muenchen GmbH, Fairgrounds, 81823 Munich, Germany.
CQDM is a pharma-based consortium active in early research whose mission is to fund the development of innovative tools and technologies to accelerate drug discovery. Unique in the world, CQDM’s business model is based on a collaborative approach where all stakeholders share the costs of biopharmaceutical research and benefit from its results. CQDM also provides a common meeting ground where academia, governments, and the pharmaceutical and biotechnology industries converge to address numerous complex medical challenges. CQDM receives financial support from Merck, Pfizer, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Eli Lilly Canada, Janssen, Novartis Pharma Canada, Sanofi Canada, as well as from Quebec’s Ministry of Economy, Innovation and Exports (MEIE) and from the Government of Canada under the Business-Led Networks of Centres of Excellence Program (BL-NCE). For more information, visit us at www.cqdm.org.
About AiF and ZIM
ZIM (Zentrales Innovationsprogramm Mittelstand / Central Innovation Program for SMEs) is a funding program from the German Federal Ministry for Economic Affairs and Energy (BMWi) intended to small and medium-sized enterprises (SMEs) with business operations in Germany that want to develop new or significantly improve existing products, processes or technical services. Public and private non-profit research and technology organizations (RTOs) acting as cooperation partners for a SME are also eligible for ZIM-funding. The goal of ZIM is to sustainably increase the innovative capacity and competitiveness of SMEs including craft businesses and independent professions. Thus the program contributes to the economic growth and creation of new jobs. It offers many funding opportunities among which the COOP program for cooperative R&D projects between SMEs or SMEs and RTOs. AiF Projekt GmbH, project management agency of BMWi, is in charge of the ZIM cooperation projects.
Senior Director, Communications and Corporate Development, CQDM
Tel.: (514) 766-6661, ext. 2198
Coordinator International Cooperation, AiF Projekt GmbH
Tel.: 030 48163-493